+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ambulatory Infusion Centers Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 181 Pages
  • August 2026
  • Region: Global
  • Grand View Research
  • ID: 6285419
REQUEST CUSTOMIZATION
Description Jump to:
The global ambulatory infusion centers market size was estimated at USD 40.9 billion in 2025 and is projected to grow from USD 43.7 billion in 2026 to USD 76.2 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 36.8% in 2025. This growth is attributed to the increasing prevalence of chronic diseases, expanding use of specialty infusion therapies, and the shift toward cost-effective outpatient care. Moreover, favorable reimbursement policies, increasing investments in independent infusion centers, and growing patient preference for convenient, accessible, and personalized infusion services are further supporting market expansion.

The section below outlines the key factors driving the growth of the ambulatory infusion centers market, highlighting the rising prevalence of chronic diseases requiring long-term infusion therapies and the growing shift from hospital-based care to cost-effective outpatient settings. It also examines the increasing adoption of specialty biologics and injectable therapies, favorable reimbursement policies, expanding investments in independent infusion centers, and rising patient preference for convenient, accessible, and personalized infusion services.

Global Ambulatory Infusion Centers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on industry trends in each of the segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the ambulatory infusion centers market report on the basis of therapy area, ownership model, age group and region:

Therapy Area Outlook (Revenue, USD Million, 2021 - 2033)

  • Oncology
  • Autoimmune & Inflammatory Disorders
  • Neurology
  • Infectious Diseases
  • Hematology
  • Immunodeficiency Disorders
  • Endocrine & Metabolic Disorders
  • Rare Diseases
  • Others

Ownership Model Outlook (Revenue, USD Million, 2021 - 2033)

  • Independent Centers
  • Hospital-Owned Centers
  • Physician-Owned Centers
  • Specialty Pharmacy-Owned Centers

Age Group Outlook (Revenue, USD Million, 2021 - 2033)

  • Pediatric
  • Adult
  • Geriatric
  • Regional Outlook (Revenue in USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • New Zealand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Therapy Area
1.1.2. Ownership Model
1.1.3. Age Group
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. The internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Therapy area outlook
2.2.2. Ownership model outlook
2.2.3. Age group outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Ambulatory Infusion Centers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising adoption of biologic and specialty drugs
3.2.1.2. Growing shift from hospital-based infusion to cost-effective ambulatory care
3.2.2. Market restraint analysis
3.2.2.1. Shortage of skilled infusion nurses and healthcare professionals
3.2.3. Market opportunity analysis
3.2.4. Market challenge analysis
3.3. Ambulatory Infusion Centers Market Analysis Tools
3.3.1. Porter’s five forces analysis
3.3.2. PESTLE analysis
Chapter 4. Ambulatory Infusion Centers Market: Therapy Area Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Therapy Area Market Share, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Ambulatory Infusion Centers Market by Therapy Area Outlook
4.4.1. Oncology
4.4.1.1. Oncology Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.2. Autoimmune & Inflammatory Disorders
4.4.2.1. Autoimmune & Inflammatory Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.3. Neurology
4.4.3.1. Neurology Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.4. Infectious Diseases
4.4.4.1. Infectious Diseases Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.5. Hematology
4.4.5.1. Hematology Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.6. Immunodeficiency Disorders
4.4.6.1. Immunodeficiency Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.7. Endocrine & Metabolic Disorders
4.4.7.1. Endocrine & Metabolic Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.8. Rare Diseases
4.4.8.1. Rare Diseases Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.9. Others
4.4.9.1. Others Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 5. Ambulatory Infusion Centers Market: Ownership Model Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Ownership Model Market Share, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Ambulatory Infusion Centers Market by Ownership Model Outlook
5.4.1. Independent Centers
5.4.1.1. Independent Centers Market estimates and forecast, 2021 to 2033 (USD Million)
5.4.2. Hospital-Owned Centers
5.4.2.1. Hospital-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
5.4.3. Physician-Owned Centers
5.4.3.1. Physician-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
5.4.4. Specialty Pharmacy-Owned Centers
5.4.4.1. Specialty Pharmacy-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 6. Ambulatory Infusion Centers Market: Age Group Estimates & Trend Analysis
6.1. Definition and Scope
6.2. Age Group Market Share, 2025 & 2033
6.3. Segment Dashboard
6.4. Global Ambulatory Infusion Centers Market by Age Group Outlook
6.4.1. Pediatric
6.4.1.1. Pediatric Market estimates and forecast, 2021 to 2033 (USD Million)
6.4.2. Adult
6.4.2.1. Adult Market estimates and forecast, 2021 to 2033 (USD Million)
6.4.3. Geriatric
6.4.3.1. Geriatric Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 7. Ambulatory Infusion Centers Market: Regional Estimates & Trend Analysis, Therapy Area, Ownership Model, Age Group
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. New Zealand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market position analysis, 2025
8.3.1. Option Care Health, Inc.
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Service benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Coram CVS Specialty Infusion Services
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Service benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Amerita, Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Service benchmarking
8.3.3.4. Strategic initiatives
8.3.4. KabaFusion
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Service benchmarking
8.3.4.4. Strategic initiatives
8.3.5. BioMatrix Specialty Pharmacy
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Service benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Paragon Healthcare, Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Service benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Healix, Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Service benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Vivo Infusion
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Service benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Pure Infusion
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Service benchmarking
8.3.9.4. Strategic initiatives
8.3.10. AIS Healthcare
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Service benchmarking
8.3.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 4 North America ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 5 North America ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 6 U.S. ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 7 U.S. ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 8 Canada ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 9 Canada ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 10 Canada ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 11 Mexico ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 12 Mexico ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 13 Mexico ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 14 Europe ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 15 Europe ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 16 Europe ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 17 UK ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 18 UK ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 19 UK ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 20 Germany ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 21 Germany ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 22 Germany ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 23 France ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 24 France ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 25 France ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 26 Italy ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 27 Italy ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 28 Italy ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 29 Spain ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 30 Spain ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 31 Spain ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 32 Sweden ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 33 Sweden ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 34 Sweden ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 35 Denmark ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 36 Denmark ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 37 Denmark ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 38 Norway ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 39 Norway ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 40 Norway ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 41 Asia Pacific ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 42 Asia Pacific ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 43 Asia Pacific ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 44 Japan ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 45 Japan ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 46 Japan ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 47 China ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 48 China ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 49 China ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 50 India ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 51 India ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 52 India ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 53 Australia ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 54 Australia ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 55 Australia ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 56 South Korea ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 57 South Korea ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 58 South Korea ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 59 Thailand ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 60 Thailand ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 61 Thailand ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 62 Latin America ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 63 Latin America ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 64 Latin America ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 65 Brazil ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 66 Brazil ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 67 Brazil ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 68 Argentina ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 69 Argentina ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 70 Argentina ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 71 MEA ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 72 MEA ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 73 MEA ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 74 South Africa ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 75 South Africa ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 76 South Africa ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 77 Saudi Arabia ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 78 Saudi Arabia ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 79 Saudi Arabia ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 80 UAE ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 81 UAE ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 82 UAE ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
Table 83 Kuwait ambulatory infusion centers market, therapy area, 2021 - 2033 (USD Million)
Table 84 Kuwait ambulatory infusion centers market, ownership model, 2021 - 2033 (USD Million)
Table 85 Kuwait ambulatory infusion centers market, age group, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Ambulatory infusion centers market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Supply-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Market segmentation
Figure 10 Market segmentation
Figure 11 Competitive landscape
Figure 12 Parent market outlook
Figure 13 Ambulatory infusion centers market dynamics
Figure 14 Ambulatory infusion centers market: Porter’s five forces analysis
Figure 15 Ambulatory infusion centers market: PESTLE analysis
Figure 16 Ambulatory infusion centers market: Therapy area segment dashboard
Figure 17 Ambulatory infusion centers market: Therapy area market share analysis, 2025 & 2033
Figure 18 Oncology ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 19 Autoimmune & inflammatory disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 20 Neurology ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 21 Infectious diseases ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 22 Hematology ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 23 Immunodeficiency disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 24 Endocrine & metabolic disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 25 Rare diseases ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 26 Others ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 27 Ambulatory infusion centers market: Ownership model segment dashboard
Figure 28 Ambulatory infusion centers market: Ownership model market share analysis, 2025 & 2033
Figure 29 Independent centers, market, 2021 - 2033 (USD Million)
Figure 30 Hospital-owned centers, market, 2021 - 2033 (USD Million)
Figure 31 Physician-owned centers, market, 2021 - 2033 (USD Million)
Figure 32 Specialty pharmacy-owned centers, market, 2021 - 2033 (USD Million)
Figure 33 Ambulatory infusion centers market: Age group segment dashboard
Figure 34 Ambulatory infusion centers market: Age group market share analysis, 2025 & 2033
Figure 35 Pediatric market, 2021 - 2033 (USD Million)
Figure 36 Adults market, 2021 - 2033 (USD Million)
Figure 37 Geriatric market, 2021 - 2033 (USD Million)
Figure 38 Ambulatory infusion centers market revenue, region, 2025 & 2033, (USD Million)
Figure 39 Regional marketplace key takeaways
Figure 40 Regional marketplace key takeaways
Figure 41 North America ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 42 Key country dynamics
Figure 43 U.S. ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 44 Key country dynamics
Figure 45 Canada ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 46 Key country dynamics
Figure 47 Mexico ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 48 Europe ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 49 Key country dynamics
Figure 50 Germany ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 51 Key country dynamics
Figure 52 UK ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 53 Key country dynamics
Figure 54 France ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 55 Key country dynamics
Figure 56 Italy ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Spain ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 Sweden ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 61 Key country dynamics
Figure 62 Norway ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 Denmark ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 65 Asia Pacific ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 Japan ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 China ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 India ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Australia ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 South Korea ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 New Zealand ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 78 Latin America ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 Brazil ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 Argentina ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 83 Middle East & Africa ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 84 Key country dynamics
Figure 85 South Africa ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 86 Key country dynamics
Figure 87 Saudi Arabia ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 88 Key country dynamics
Figure 89 UAE ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 90 Key country dynamics
Figure 91 Kuwait ambulatory infusion centers market, 2021 - 2033 (USD Million)
Figure 92 Company/competition categorization
Figure 93 Company market position analysis, 2025
Figure 94 Strategy mapping

Companies Mentioned

  • Option Care Health, Inc.
  • Coram CVS Specialty Infusion Services
  • Amerita, Inc.
  • KabaFusion
  • BioMatrix Specialty Pharmacy
  • Paragon Healthcare, Inc.
  • Healix, Inc.
  • Vivo Infusion
  • Pure Infusion
  • AIS Healthcare

Related Reports

U.S. Dialysis Furniture Market Size, Share & Trends Analysis Report by Product (Dialysis Chairs, Task Chairs/Treatment Tables), Modality/Use, End Use with Growth Forecasts, 2025-2033 - Product Image

U.S. Dialysis Furniture Market Size, Share & Trends Analysis Report by Product (Dialysis Chairs, Task Chairs/Treatment Tables), Modality/Use, End Use with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • United States
From
U.S. Pressure Infusor Market Size, Share & Trends Analysis Report by Product, Capacity, Application, End Use, Region, and Growth Forecasts, 2026-2033 - Product Image

U.S. Pressure Infusor Market Size, Share & Trends Analysis Report by Product, Capacity, Application, End Use, Region, and Growth Forecasts, 2026-2033

  • Report
  • 90 Pages
  • United States
From
Ambulatory Infusion Pumps Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Ambulatory Infusion Pumps Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 195 Pages
  • Global
From
Elastomeric Infusion Pumps Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Elastomeric Infusion Pumps Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 200 Pages
  • Global
From
North America Intravenous Solutions Market Size, Share & Trends Analysis Report by Type, Nutrients, End Use, Country, and Segment Forecasts, 2026-2033 - Product Image

North America Intravenous Solutions Market Size, Share & Trends Analysis Report by Type, Nutrients, End Use, Country, and Segment Forecasts, 2026-2033

  • Report
  • 120 Pages
  • North America
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.